The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) subvariant BA.2.86 was first reported in Denmark early in August 2023. 1 By August 30, a total of 24 cases had been detected in 8 ...
Difference between skin toxicities in erlotinib (E) and gefitinib (G) in the treatment of advanced non-small cell lung cancer (NSCLC) ...
Announcing a new article publication for Zoonoses journal. The COVID-19 pandemic, which was caused by SARS-CoV-2, has had a significant effect on global public health, economies, and societies ...
A recent review highlighted several candidate biomarkers for diagnosing axial spondyloarthritis associated with inflammatory bowel disease in early phases. A recent review highlighted several ...
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19” was ...
Autoimmune disorders occur when the body’s immune system cannot differentiate between cells that are its own and pathogens. Consequently, the body’s immune system attacks itself causing inflammation ...
In a recent observational study published in the journal Immunity, researchers from the United States of America investigated the longevity of antibody responses to severe acute respiratory syndrome ...
Prior exposure to one strain of influenza virus may weaken children's ability to mount an effective antibody response against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results